GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Gross Margin %

HeXun Biosciences Co (ROCO:6986) Gross Margin % : 92.72% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. HeXun Biosciences Co's Gross Profit for the six months ended in Jun. 2024 was NT$123.7 Mil. HeXun Biosciences Co's Revenue for the six months ended in Jun. 2024 was NT$133.4 Mil. Therefore, HeXun Biosciences Co's Gross Margin % for the quarter that ended in Jun. 2024 was 92.72%.


The historical rank and industry rank for HeXun Biosciences Co's Gross Margin % or its related term are showing as below:

ROCO:6986' s Gross Margin % Range Over the Past 10 Years
Min: 87.1   Med: 88.64   Max: 91.67
Current: 91.67


During the past 4 years, the highest Gross Margin % of HeXun Biosciences Co was 91.67%. The lowest was 87.10%. And the median was 88.64%.

ROCO:6986's Gross Margin % is ranked better than
88.43% of 743 companies
in the Biotechnology industry
Industry Median: 60.3 vs ROCO:6986: 91.67

HeXun Biosciences Co had a gross margin of 92.72% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for HeXun Biosciences Co was 0.00% per year.


HeXun Biosciences Co Gross Margin % Historical Data

The historical data trend for HeXun Biosciences Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Gross Margin % Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Margin %
- - 90.18 87.10

HeXun Biosciences Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Margin % Get a 7-Day Free Trial 35.61 92.14 75.13 90.30 92.72

Competitive Comparison of HeXun Biosciences Co's Gross Margin %

For the Biotechnology subindustry, HeXun Biosciences Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeXun Biosciences Co's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's Gross Margin % falls into.



HeXun Biosciences Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

HeXun Biosciences Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=113.7 / 130.571
=(Revenue - Cost of Goods Sold) / Revenue
=(130.571 - 16.838) / 130.571
=87.10 %

HeXun Biosciences Co's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=123.7 / 133.373
=(Revenue - Cost of Goods Sold) / Revenue
=(133.373 - 9.708) / 133.373
=92.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


HeXun Biosciences Co  (ROCO:6986) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

HeXun Biosciences Co had a gross margin of 92.72% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


HeXun Biosciences Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HeXun Biosciences Co Business Description

Traded in Other Exchanges
N/A
Address
Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines